To include your compound in the COVID-19 Resource Center, submit it here.

AVP-923: Started Phase II/III trial

Avanir Pharmaceuticals (AVN), San Diego, Calif.
Product: AVP-923
Business:

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE